local
An experimental Alzheimer's drug shows some promise as researchers hunt new approaches
By Lauran Neergaard, Associated Press at KPRC 2 / Click2Houston (NBC)
· July 14, 2026
· 5 min read
An experimental drug might help slow early Alzheimer’s disease in a markedly different way than today’s treatments — by lowering levels of a brain protein called tau, researchers reported Tuesday.Tau is one part of a toxic duo fueling Alzheimer’s but prior attempts to develop drugs that can targe...
Key takeaway “This is really quite promising if it were to hold up” in that next-step testing, said Jessica Langbaum of the Banner Alzheimer’s Institute in Phoenix, who wasn’t involved with Biogen’s study.
Why this matters in The Piney Point
For residents of Piney Point Village , the prospect of a new Alzheimer's treatment is particularly significant given the city's demographics. As part of the Houston area, Piney Point Village is home to a sizable population of older adults who may be at risk for Alzheimer's disease. The potential of Biogen's diranersen to slow cognitive decline by targeting tau protein could bring hope to local families affected by the disease. Furthermore, the Houston area is also home to a robust medical research community, which could play a role in future studies of diranersen and other novel Alzheimer's treatments. As researchers move forward with larger studies, Piney Point Village residents may have opportunities to participate in clinical trials or benefit from new treatments developed through local research institutions. The pursuit of innovative Alzheimer's therapies like diranersen underscores the need for continued investment in medical research and highlights the potential for local communities to contribute to breakthroughs in the fight against this devastating disease.
About this story
Original reporting by KPRC 2 / Click2Houston (NBC) . The Piney Point surfaces reporting from trusted publishers and adds local editorial context so readers can quickly understand what a story means for their community. We attribute every source, link to the original report, and follow a documented editorial standards policy. To understand how stories are selected and reviewed, read our about page .
For the complete original report, visit KPRC 2 / Click2Houston (NBC) . Have a tip or correction? Contact our newsroom .
Category: local ·
Published: July 14, 2026 ·
Source: KPRC 2 / Click2Houston (NBC) ·
Reading time: 5 min
Get more The Piney Point stories like this
Free weekly briefing covering local and other local news. Curated by our editorial team. No spam.
By subscribing you agree to our privacy policy . Unsubscribe anytime.
Frequently asked about this story
What is this story about? An experimental drug might help slow early Alzheimer’s disease in a markedly different way than today’s treatments — by lowering levels of a brain protein called tau, researchers reported Tuesday.Tau is one part of a toxic duo fueling Alzheimer’s but prior attempts to develop drugs that can targe...
When was this published? This article was first published on July 14, 2026 by KPRC 2 / Click2Houston (NBC) and curated for The Piney Point readers.
Who reported this story? This story was reported by Lauran Neergaard, Associated Press at KPRC 2 / Click2Houston (NBC). To learn more about how The Piney Point selects and reviews stories, see our editorial standards .
Where can I find related coverage? See more local coverage from The Piney Point, or browse our daily briefing and topic hubs .
← Back to all news
More local →
Today’s briefing
Subscribe to newsletter